Literature DB >> 2280114

A longitudinal study of the incidence of leprosy in a hyperendemic area in Zaire, with special reference to PGL-antibody results. The Yalisombo Study Group.

G Groenen1, S R Pattyn, P Ghys, K Tshilumba, L Kuykens, M J Colston.   

Abstract

Between 1984 and 1988, yearly surveys for leprosy were done among the 1500 people living in a previous leprosy segregation village in Zaire. In 1984 lepromin tests and phenolic glycolipid (PGL) antibody tests were done in a significant part of the population. The prevalence of the disease at that time was 16.1%, the proportion of multibacillary cases was 11.3% overall and 22% among active cases. Prior to 1984, 23% of paucibacillary cases and 56% of multibacillary cases had presented themselves spontaneously to the Leprosy Service. The exposure to the infection is uniform, but there is a suggestion of family clustering of cases. In spite of a rapidly bactericidal treatment of all known cases in 1984 and thereafter, the annual incidence of 0.34% did not decrease during the 4 years of the study. The PGL antibody test did not contribute to the diagnosis, classification or prognosis of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280114

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  5 in total

1.  Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients.

Authors:  J Serafín-López; M Talavera-Paulin; J C Amador-Molina; M Alvarado-Riverón; M M Vilchis-Landeros; P Méndez-Ortega; M Fafutis-Morris; V Paredes-Cervantes; R López-Santiago; C I León; M I Guerrero; R M Ribas-Aparicio; G Mendoza-Hernández; C Carreño-Martínez; S Estrada-Parra; I Estrada-García
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.

Authors:  Nádia C Düppre; Luiz Antonio B Camacho; Anna M Sales; Ximena Illarramendi; José Augusto C Nery; Elizabeth P Sampaio; Euzenir N Sarno; Samira Bührer-Sékula
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

3.  Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.

Authors:  Renate A Richardus; Konrad van der Zwet; Anouk van Hooij; Louis Wilson; Linda Oskam; Roel Faber; Susan J F van den Eeden; David Pahan; Khorshed Alam; Jan Hendrik Richardus; Annemieke Geluk
Journal:  PLoS Negl Trop Dis       Date:  2017-12-11

4.  Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.

Authors:  Fernanda Marques de Carvalho; Luciana Silva Rodrigues; Nádia Cristina Duppre; Iris Maria Peixoto Alvim; Marcelo Ribeiro-Alves; Roberta Olmo Pinheiro; Euzenir Nunes Sarno; Maria Cristina Vidal Pessolani; Geraldo Moura Batista Pereira
Journal:  PLoS Negl Trop Dis       Date:  2017-05-03

Review 5.  Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis.

Authors:  Maria Lucia F Penna; Gerson O Penna; Paula C Iglesias; Sonia Natal; Laura C Rodrigues
Journal:  PLoS Negl Trop Dis       Date:  2016-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.